Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Angiotech Pharmaceuticals (NasdaqNM:ANPI)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | Msgs
Recent Events
Aug 14Conference call: Angiotech Pharmaceuticals Earnings (Q3 2001)
Aug 14Earnings Announcement
Location
6660 N.W. Marine Drive
British Columbia, V6T 1Z4
Vancouver, Canada
Phone: (604) 221-7676
Fax: (604) 221-1122
Email: info@angio.com
Employees (last reported count): 50
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Biotechnology & Drugs
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 6%
·Institutional: 15% (15% of float)
(51 institutions)
·Net Inst. Buying: 252.0K shares (+10.13%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Angiotech Pharmaceuticals is a Canadian pharmaceutical company dedicated to the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug, paclitaxel. These treatments are based upon the Company's discovery that paclitaxel, one of the most commercially successful and clinically effective anticancer drugs ever produced, also blocks an important cellular pathway involved in inflammation.
More from Market Guide: Expanded Business Description

Financial Summary
Angiotech Pharmaceuticals is a Pharmaceutical company engaged in the development of medical device coatings and treatments for chronic inflammatory diseases through reformulation of the anticancer drug Paclitaxel. For the nine months ended 6/30/01, revenues fell from C$4.5 million to C$0. Net loss rose from C$2.4 million to C$8.4 million. Revenues reflect the absence of license and contract research fees. Higher loss reflects higher R&D, administrative and amortization costs.
More from Market Guide: Significant Developments

Officers

Position
William Hunter, M.D.Chairman, CEO
Donald Longenecker, Ph.D.Pres, COO, Director
David HallSr. VP-Fin.
David HartnettSr. VP, Operations
David McMastersVP, Intellectual Property, Gen. Counsel
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:ANPIAs of 31-Aug-2001
Price and Volume
52-Week Low
on 22-Mar-2001
$35.50 
Recent Price$57.05 
52-Week High
on 6-Nov-2000
$65.50 
Daily Volume (3-month avg)30.5K
Daily Volume (10-day avg)130.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y]
52-Week Change+27.1%
52-Week Change
relative to S&P500
+70.6%
Share-Related Items
Market Capitalization$877.7M
Shares Outstanding15.4M
Float14.5M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$6.56 
Earnings (ttm)-$0.33 
Earnings (mrq)-$0.28 
SalesN/A 
Cash (mrq)$6.46 
Valuation Ratios
Price/Book (mrq)8.70 
Price/EarningsN/A 
Price/SalesN/A 
Income Statements
Sales (ttm)-$1,000 
EBITDA (ttm)-$12.6M
Income available to common (ttm)-$5.07M
Profitability
Profit MarginN/A 
Operating MarginN/A 
Fiscal Year
Fiscal Year EndsSep 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)-4.78%
Return on Equity (ttm)-4.86%
Financial Strength
Current Ratio (mrq)65.68 
Debt/Equity (mrq)0 
Total Cash (mrq)$99.8M
Short Interest
As of 8-Aug-2001
Shares Short137.0K
Percent of Float0.9%
Shares Short
(Prior Month)
137.0K
Short Ratio17.12 
Daily Volume8,000 
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001);   dollar amounts based on an exchange rate of 1.55 Canadian Dollars/US Dollar

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Some event data provided by CCBN. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.